Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lung cancer drug: AstraZeneca India wins CDSCO nod for Durvalumab for specified additional indication

Ruchika Sharma24 Sept 2024 12:00 PM IST

Bengaluru: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Merck gets positive EU CHMP opinions for Keytruda regimens for patients with two types of Gynecologic cancers

Ruchika Sharma24 Sept 2024 10:00 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...

Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label Update

Eli Lilly planning expansion of research centre in India: CEO David Ricks

Ruchika Sharma24 Sept 2024 10:00 AM IST

New York: Eli Lilly is planning the expansion of its research centre in India and will be partnering with other Indian companies. Eli Lilly CEO...

USFDA nod to Merck KEYTRUDA plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

Ruchika Sharma23 Sept 2024 7:26 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S.Food and Drug Administration (FDA) has approved KEYTRUDA,...

Raid: Certain banned drugs seized in Vadodara, 1 detained

Ruchika Sharma23 Sept 2024 4:24 PM IST

Vadodara: Certain banned drugs were seized during a recent raid of the Central Bureau of Narcotics (CBN) on a pharmaceutical company on Ravpura...

J&K sets up first Jan Aushadi medical store at Nowgam railway station

Ruchika Sharma23 Sept 2024 1:00 PM IST

Srinagar: In a significant step towards providing affordable medicines to the public, the government of Jammu and Kashmir has opened the first...

Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance Officer

USFDA concludes inspection at Biocon Bengaluru API facility

Ruchika Sharma23 Sept 2024 12:06 PM IST

Bangalore: Biocon has announced that the U.S. Food and Drug Administration (US FDA) has concluded a surveillance inspection at the Company's...

Unichem Labs Roha facility gets 3 USFDA observations

Aarti Drugs gets 7 inspectional USFDA observations for Tarapur facility

Ruchika Sharma23 Sept 2024 11:00 AM IST

Maharashtra: Aarti Drugs Limited has announced that the United States Food and Drug Administration (US FDA) has issued 7 inspectional...

Dupixent recommended for EU approval by CHMP to treat eosinophilic esophagitis in children as young as 1 year old: Sanofi

Ruchika Sharma22 Sept 2024 1:30 PM IST

Paris: Sanofi has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...

Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International

Darzalex-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma

Ruchika Sharma22 Sept 2024 12:30 PM IST

Beerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...

JnJ gets USFDA nod for Rybrevant plus standard of care chemotherapy for lung cancer treatment

Ruchika Sharma21 Sept 2024 4:00 PM IST

Raritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) in...

Sanofi Rilzabrutinib earns orphan designation in EU for IgG4 related disease

USFDA nod to Sanofi Sarclisa in combo with bortezomib, lenalidomide, dexamethasone for newly diagnosed multiple myeloma not eligible for transpant

Ruchika Sharma21 Sept 2024 2:25 PM IST

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Sarclisa (isatuximab) in combination with bortezomib,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok